Dawn Svoronos - 09 Jun 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Reporting relationship: Director
Issuer ticker: PTCT
Reported as of: 09 Jun 2022
Net transaction value: -$20,074
SEC form: 4
Accepted by SEC: 10 Jun 2022, 16:06:01 UTC
Prior SEC filing: 18 May 2022
Next SEC filing: 14 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Avraham S. Adler, Attorney-in-Fact

Key filing fact

Dawn Svoronos filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 10 Jun 2022.

Key facts

This page summarizes Dawn Svoronos's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2022, 16:06.

Change

Previous filing in this sequence was filed on 18 May 2022.
Current net transaction value: -$20,074.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTCT transaction

Common Stock

Sale

Transaction value: $20,074
Shares: -738
Change %: -2.5%
Price: $27.20
Shares after: 29,017
Date: 09 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,333 RSUs from a January 7, 2022 grant of 3,200 RSUs.